首页> 外文期刊>Molecules >Synthesis of Novel Benzodifuranyl; 1,3,5-Triazines; 1,3,5-Oxadiazepines; and Thiazolopyrimidines Derived from Visnaginone and Khellinone as Anti-Inflammatory and Analgesic Agents
【24h】

Synthesis of Novel Benzodifuranyl; 1,3,5-Triazines; 1,3,5-Oxadiazepines; and Thiazolopyrimidines Derived from Visnaginone and Khellinone as Anti-Inflammatory and Analgesic Agents

机译:新型苯并二氰基的合成; 1,3,5-三嗪; 1,3,5-氧基亚卓病;和硫代吡啶胺衍生自Visnaginone和Khellinone作为抗炎和镇痛剂

获取原文
           

摘要

Novel (4-methoxy or 4,8-dimethoxy)-3-methyl-N-(6-oxo-2-thioxo-1,2,3, 6-tetrahydro- pyrimidin-4-yl) benzo [1,2-b: 5, 4-b’] difuran-2-carboxamide (5a–b) has been synthesized by the reaction of visnagenone–ethylacetate (2a) or khellinone–ethylacetate (2b) with 6-aminothiouracil in dimethylformamide or refluxing of benzofuran-oxy-N-(2-thioxopyrimidine) acetamide (4a–b) in sodium ethoxide to give the same products (5a,b) in good yields. Thus, compounds 5a–b are used as an initiative to prepare many new heterocyclic compounds such as 2-(4-(3-methylbenzodifuran- 2-carbox-amido) pyrimidine) acetic acid (6a–b), N-(thiazolo[3, 2-a]pyrimidine)-3-methylbenzo- difuran-2-carboxamide (7a–b), N-(2-thioxopyrimidine)-methylbenzodifuran-2-carbimidoylchloride (8a–b), N-(2-(methyl-thio) pyrimidine)-3-methylbenzodifuran-2-carbimidoylchloride (9a–b), N-(2, 6 -di(piperazine or morpholine)pyrimidine)-1-(3-methylbenzodifuran)-1-(piperazine or morpholine) methanimine(10a–d), 8-(methylbenzodifuran)-thiazolopyrimido[1,6-a][1,3,5]triazine-3,5-dione (11a –b), 8-(3-methyl benzodifuran)-thiazolopyrimido[6,1-d][1,3,5]oxadiazepine-trione (12a–b), and 2,10 -di(sub-benzylidene)-8-(3-methylbenzodifuran)-thiazolopyrimido[6,1-d][1,3,5]oxadiazepine-3,5,11- trione (13a–f). All new chemical structures were illustrated on the basis of elemental and spectral analysis (IR, NMR, and MS). The new compounds were screened as cyclooxygenase-1/ cyclooxygenase-2 (COX-1/COX-2) inhibitors and had analgesic and anti-inflammatory activities. The compounds 10a–d and 13a–f had the highest inhibitory activity on COX-2 selectivity, with indices of 99–90, analgesic activity of 51–42% protection, and anti-inflammatory activity of 68%–59%. The inhibition of edema for the same compounds, 10a–d and 13a–f, was compared with sodium diclofenac as a standard drug.
机译:新型(4-甲氧基或4,8-二甲氧基)-3-甲基-N-(6-氧代-2-硫代氧基-1,2,3,6-四羟基吡啶胺-4-基)苯并[1,2- B:5,4-B']通过visnagenone-乙酸乙酯(2a)或khellinone-乙酸乙酯(2b)与6-氨基甲酰胺的反应合成了DiFuran-2-甲酰胺(5a-b),用二甲基甲酰胺或苯并呋喃回流 - 氧化钠中的氧基 - N-(2-噻嗪嘧啶)乙酰胺(4A-B),得到相同的产物(5A,B)。因此,化合物5a-b用作制备许多新的杂环化合物,例如2-(4-(3-甲基苯并二亚甲基 - 羧基-mido)嘧啶)乙酸(6a-b),n-(噻唑洛[ 3,2-a]嘧啶)-3-甲基苯并 - difuran-2-甲酰胺(7a-b),N-(2-硫代吡啶)-methylbenzodifuran-2-碳酰亚胺氯化物(8a-b),n-(2-(甲基 - 硫基)嘧啶)-3-甲基苯并二亚丙酰氯(9a-b),n-(2,6 -di(哌嗪或正文)嘧啶)-1-(3-甲基苯并二氰)-1-(哌嗪或吗啉)甲基亚胺(10A-D),8-(甲基苯并二氰) - 噻唑吡嘧啶[1,6-A] [1,3,5]三嗪-3,5-二酮(11A-3),8-(3-甲基苯二呋喃) - 噻唑吡喃嘧啶[6,1-d] [1,3,5]恶二氮杂-Trione(12a-b)和2,10-di(亚苄基)-8-(3-甲基苯并二亚氨酸) - 噻唑吡喃胺[6,1- D] [1,3,5]氧基亚卓-3,5,11-三季(13A-F)。基于元素和光谱分析(IR,NMR和MS)来说明所有新化学结构。将新化合物筛选为环氧氧基酶-1 /环氧酶-2(COX-1 / COX-2)抑制剂并具有镇痛和抗炎活动。化合物10A-D和13A-F对COX-2选择性具有最高的抑制活性,具有99-90的索引,镇痛活性为51-42%,抗炎活性为68%-59%。将对相同化合物,10A-D和13A-F的水肿的抑制与双氯芬酸钠作为标准药物进行比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号